<DOC>
	<DOCNO>NCT01433575</DOCNO>
	<brief_summary>This single-center , open-label , single dose , randomize , two-way cross-over study evaluate pharmacokinetics , safety tolerability RO4917838 healthy Chinese volunteer . Subjects randomize receive single oral dose either 10 mg 20 mg RO4917838 , washout period least 21 35 day , re-dosed alternative treatment . Anticipated time study 70 day .</brief_summary>
	<brief_title>A Pharmacokinetic Study RO4917838 Healthy Chinese Volunteers</brief_title>
	<detailed_description />
	<criteria>Healthy Chinese male female volunteer , 18 45 year age inclusive time screen Healthy status define absence evidence active chronic disease disorder follow detailed medical surgical history complete physical examination Body mass index ( BMI ) 19 28 kg/m2 inclusive Pregnant currently lactate female History clinically relevant disorder Any history depressive episode treatment antidepressant History drug abuse within past 2 year positive result drug abuse screen Day 1 Alcohol dependence history within past 2 year positive result alcohol breath test screen Day 1 Positive HIV , hepatitis B hepatitis C infection Regular smoker consumption 10 cigarette day equivalent amount tobacco Participation clinical study investigational drug device within last 3 month prior dose Medical history significant drug allergy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>